Search research articles
Contact Us
Filters
Showing results (1-10 of 56) with videos related to
Page
of 6
Sort By:
Current Opinion in Critical Care
|
March 26, 2021
Inhaled gases as novel neuroprotective therapies in the postcardiac arrest period
Aurora Magliocca, Michael Fries
Current Opinion in Critical Care
|
June 2, 2005
How does interruption of cardiopulmonary resuscitation affect survival from cardiac arrest?
Michael Fries, Wanchun Tang
Critical Care Medicine
|
December 15, 2005
In-hospital cardiac arrest
Max Harry Weil, Michael Fries
Clinical Pharmacology in Drug Development
|
May 4, 2016
A single- and multiple-dose study to investigate the pharmacokinetics of epelsiban and its metabolite, GSK2395448, in healthy female volunteers
Kelly M Mahar, Brendt Stier, Michael Fries, et al.
Journal of Occupational and Environmental Hygiene
|
April 20, 2018
Airborne exposures associated with the typical use of an aerosol brake cleaner during vehicle repair work
Michael Fries, Pamela R D Williams, Jerald Ovesen, et al.
Critical Care (London, England)
|
April 17, 2009
Changes in S-100 protein serum levels in survivors of out-of-hospital cardiac arrest treated with mild therapeutic hypothermia: a prospective, observational study
Matthias Derwall, Christian Stoppe, David Brücken, et al.
Journal of Critical Care
|
March 31, 2009
Influence of mild therapeutic hypothermia on the inflammatory response after successful resuscitation from cardiac arrest
Michael Fries, Christian Stoppe, David Brücken, et al.
Critical Care Medicine
|
May 8, 2010
Neuroprotective effects of the inhalational anesthetics isoflurane and xenon after cardiac arrest in pigs
Matthias Derwall, Anne Timper, Kai Kottmann, et al.
Resuscitation
|
October 29, 2003
Procalcitonin serum levels after out-of-hospital cardiac arrest
Michael Fries, Dagmar Kunz, Axel M Gressner, et al.
Current Medical Research and Opinion
|
October 26, 2022
Comprehensive analysis and prediction of long-term durability of factor IX activity following etranacogene dezaparvovec gene therapy in the treatment of hemophilia B
Jinesh Shah, Hongseok Kim, Krupa Sivamurthy, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 56) with videos related to
Sort By:
Page
of 6
Current Opinion in Critical Care
|
March 26, 2021
Inhaled gases as novel neuroprotective therapies in the postcardiac arrest period
Aurora Magliocca, Michael Fries
Current Opinion in Critical Care
|
June 2, 2005
How does interruption of cardiopulmonary resuscitation affect survival from cardiac arrest?
Michael Fries, Wanchun Tang
Critical Care Medicine
|
December 15, 2005
In-hospital cardiac arrest
Max Harry Weil, Michael Fries
Clinical Pharmacology in Drug Development
|
May 4, 2016
A single- and multiple-dose study to investigate the pharmacokinetics of epelsiban and its metabolite, GSK2395448, in healthy female volunteers
Kelly M Mahar, Brendt Stier, Michael Fries, et al.
Journal of Occupational and Environmental Hygiene
|
April 20, 2018
Airborne exposures associated with the typical use of an aerosol brake cleaner during vehicle repair work
Michael Fries, Pamela R D Williams, Jerald Ovesen, et al.
Critical Care (London, England)
|
April 17, 2009
Changes in S-100 protein serum levels in survivors of out-of-hospital cardiac arrest treated with mild therapeutic hypothermia: a prospective, observational study
Matthias Derwall, Christian Stoppe, David Brücken, et al.
Journal of Critical Care
|
March 31, 2009
Influence of mild therapeutic hypothermia on the inflammatory response after successful resuscitation from cardiac arrest
Michael Fries, Christian Stoppe, David Brücken, et al.
Critical Care Medicine
|
May 8, 2010
Neuroprotective effects of the inhalational anesthetics isoflurane and xenon after cardiac arrest in pigs
Matthias Derwall, Anne Timper, Kai Kottmann, et al.
Resuscitation
|
October 29, 2003
Procalcitonin serum levels after out-of-hospital cardiac arrest
Michael Fries, Dagmar Kunz, Axel M Gressner, et al.
Current Medical Research and Opinion
|
October 26, 2022
Comprehensive analysis and prediction of long-term durability of factor IX activity following etranacogene dezaparvovec gene therapy in the treatment of hemophilia B
Jinesh Shah, Hongseok Kim, Krupa Sivamurthy, et al.
Page
of 6